Elsevier's Clinical Pharmacology Now Accessible Through Elsevier Infobutton

 Elsevier's Clinical Pharmacology Now Accessible Through Elsevier Infobutton

  PR Newswire

  TAMPA, Florida, November 28, 2012

TAMPA, Florida, November 28, 2012 /PRNewswire/ --

      Elsevier Infobutton now links from EHRs to key content in Clinical

Elsevier's Gold Standard , a leading drug information provider, announced
today that its Clinical Pharmacology drug reference solution will be
accessible through the recently launched Elsevier Infobutton , a one-touch
service that links from an EHR (electronic health record) to evidence-based
content in Elsevier electronic information solutions. Institutions with an
EHR can license and then link to Elsevier's comprehensive drug reference
content in Clinical Pharmacology through clinical terms in the patient record.

The Elsevier Infobutton helps providers achieve EHR certification for Stage 2
Meaningful Use by supporting these HL7 (Health Level Seven International)
Infobutton standard use cases:

  *Context--sensitive links that reference information to support clinical
  *Links to patient-specific education resources

Clinical Pharmacology is trusted by more than 2,000 hospitals nationwide and
is accepted as a professional drug reference by all 50 State Boards of

"The Elsevier Infobutton demonstrates real value at the point-of-care by
simplifying access to clinical decision support information and patient
education materials that improve care and patient outcomes," said Marianne
Messer, President, Elsevier's Gold Standard. "Our goal continues to focus on
providing solutions that elevate the standard of care through
easily-accessible, user-friendly, evidence-based drug information."

The Elsevier Infobutton is offered free-of-charge to customers with an EHR who
also license other Elsevier electronic information products, including
Clinical Pharmacology, Mosby's Nursing Consult and Mosby's Skills.

For more information about Elsevier Infobutton please visit
http://www.elsinfobutton.com .

About Elsevier's Gold Standard

Based in Tampa, FL, Elsevier's Gold Standard uses innovative technologies to
provide a complete suite of drug information and decision support solutions.
With a tenacious commitment to product quality, Elsevier's Gold Standard
solutions empower healthcare organizations, professionals and consumers to
meet the most pressing healthcare challenges, improve patient safety and
ensure optimal outcomes. To learn more about Elsevier's Gold Standard, visit
http://www.goldstandard.com .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Christopher Capot Director, Corporate Relations Elsevier
+1-212-633-3164 c.capot@elsevier.com
Press spacebar to pause and continue. Press esc to stop.